Director/PDMR Shareholding

RNS Number : 7823S

Hikma Pharmaceuticals Plc

13 March 2019

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083
b)	Nature of the transaction	Market purchase of 20,000 Ordinary Shares by Capital Investment & Brokerage / Jordan Ltd. Co for and on behalf of Mazen Darwazah.
c)	Price(s) and volume(s)	Price(s): £15.8198 Volume(s): 20,000
d)	Aggregated information -       Volume -       Price	20,000 £316,396.00
e)	Date of the transaction	13 March 2019
f)	Place of the transaction	London Stock Exchange (XLON)

Peter Speirs
Company Secretary, responsible for releasing this announcement
[phone]

13 March 2019

 

END

 

 

DSHBXGDXISBBGCX